Alyssa M Peckham

ORCID

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 11

Top Venues

The mental health clinician

Open forum infectious diseases

Substance abuse : research and treatment

Expert opinion on drug safety

Northeastern University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Northeastern University Jul 02 2018

United States

Assistant Clinical Professor :: Pharmacy

Midwestern University Jul 29 2016 - Jul 01 2018

United States

Assistant Professor :: Department of Pharmacy Practice

Publications

Alyssa M Peckham, Jordan R Covvey, Kirk E Evoy
Letter to the Editor: Comment on "Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth". Pain and therapy 10 (1) (2021)
Jonathan P DeWeese, James R Krenz, Sarah E Wakeman, Alyssa M Peckham
Rapid buprenorphine microdosing for opioid use disorder in a hospitalized patient receiving very high doses of full agonist opioids for acute pain management: Titration, implementation barriers, and strategies to overcomes. Substance abuse 42 (4) (2021)
Kirk E Evoy, Sarvnaz Sadrameli, Jillian Contreras, Jordan R Covvey, Alyssa M Peckham
Authors' Reply to Bonnet et al. "Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update". Drugs 81 (5) (2021)
Payal H Desai, Olesya Taylor, Kunal J Shah, Kirk E Evoy, Alyssa M Peckham
Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids. The mental health clinician 11 (4) (2021)
Alyssa M Peckham, Erika H Young
Opportunities to Offer Harm Reduction to People who Inject Drugs During Infectious Disease Encounters: Narrative Review. Open forum infectious diseases 7 (11) (2020)
Alyssa M Peckham, Austin De La Cruz, Robert L Dufresne
Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression? The mental health clinician 8 (4) (2018)
Alyssa M Peckham, Kirk E Evoy, Leslie Ochs, Jordan R Covvey
Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern? Substance abuse : research and treatment 12 (2018)
Alyssa M Peckham, Kathleen A Fairman, David A Sclar
All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population. Drug safety 41 (2) (2018)
Alyssa M Peckham, Jessica A Nicewonder
VMAT2 Inhibitors for Tardive Dyskinesia-Practice Implications. Journal of pharmacy practice 32 (4) (2018)
Alyssa M Peckham, Kirk E Evoy, Jordan R Covvey, Leslie Ochs, Kathleen A Fairman, David A Sclar
Predictors of Gabapentin Overuse With or Without Concomitant Opioids in a Commercially Insured U.S. Population. Pharmacotherapy 38 (4) (2018)
Alyssa M Peckham, Kathleen A Fairman, David A Sclar
Policies to mitigate nonmedical use of prescription medications: how should emerging evidence of gabapentin misuse be addressed? Expert opinion on drug safety 17 (5) (2017)

Alyssa M Peckham.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Alyssa M Peckham